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events were compared between two groups, and independent predictors of prognosis
were also identiﬁed.
Results: Compared with patients in control group, those in IAS group had higher
ratio of hypertension (P<0.05). During follow-up (mean 5212 months), 42 cases
of end point events were recorded, including 20 major adverse cardiac events
(MACE). The rate of MACE (IAS group vs control group, 18.4% vs 3.6%,
RR¼6.03, 95% CI 1.94-18.77, P¼0.001) and end point events (33.3% vs 11.7%,
RR¼3.79, 95% CI 1.82-7.82, P<0.001) were signiﬁcantly higher in IAS group.
Multivariate Cox regression analysis revealed that CPP>45 mmHg (RR¼3.86,
95% CI 1.89-7.87, P<0.001), common carotid atherosclerotic plaque (RR¼2.17,
95% CI 1.38-3.41, P¼0.001), multivessel CAD (RR¼1.70, 95% CI1.24-2.34,
P¼0.001) and a prior history of cerebral vascular disease (RR¼3.26, 95% CI1.41-
7.52, P¼0.006) were independent predictors of prognosis of cardiovascular
diseases.
Conclusions: CPP >45mmHg and common carotid atherosclerotic plaque were in-
dependent predictors of adverse cardiac events. The results indicated a high value of
noninvasive arterial stiffness index estimation for prognosis.
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Effect of the combined increase of C-reactive protein and uric acid level on
metabolic syndrome and its components
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Objectives: The combined effect of C-reactive protein (hs-CRP) and uric acid on
progression of metabolic syndrome (MS) is inadequately deﬁned. The aim of this
study is to evaluate the effect of the combined increase of high-sensitivity
C-reactive protein (hs-CRP) and uric acid (UA) on metabolic syndrome and its
components.
Methods: A total of 21936 subjects who took well-man or -woman check up in our
hospital were enrolled. Hs-CRP, uric acid, fasting plasma glucose, lipid proﬁle, waist
circumference and blood pressure were measured to analyze the relationship between
metabolic syndrome and its components with hs-CRP and uric acid in three groups
(low-risk group: hs-CRP<1 md/dL, mid-risk group: hs-CRP 1w3 md/dL, high-risk
group: hs-CRP>3 md/dL).
Results: (1) As hs-CRP values increased, waist circumference, uric acid, tri-
glycerides, fasting plasma glucose, systolic blood pressure, diastolic blood pressure
and high-density lipoprotein increased among the three groups. F values were 86.38,
41.11, 23.37, 18.56, 19.22, 17.88 and 12.23 separately (P<0.01). (2) Mid and high-
risk groups of hs-CRP with hyperuricemia were closely related to waist circumfer-
ence, triglycerides and systolic blood pressure. OR values were 3.26, 3.27, 1.59 and
3.77, 3.38, 1.64 separately (P<0.05). (3) The incidence of metabolic syndrome
increased gradually with the combined increases of hs-CRP and uric acid, they were
49.06% and 55.59% in the mid and high-risk groups of hs-CRP with hyperuricemia
(P<0.01).
Conclusions: With increased values of both hs-CRP and uric acid, metabolic dis-
orders tended to be worse and the incidence of metabolic syndrome was increased.
Hs-CRP and uric acid can be used as a clinical predicting or monitoring item
for MS.
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Effects of tea intake on blood pressure: a meta-analysis of 21 randomized
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Objectives: The effect of tea intake on blood pressure (BP) is controversial. We
undertook a meta-analysis of randomized controlled trials to determine changes in
systolic and diastolic BP due to the intake black and green tea.
Methods: MEDLINE, EMBASE, and the Cochrane Controlled Trials Register were
searched from 1966 until January 2014 for studies in parallel group or crossover
design in which BP was assessed before and after receiving black or green tea for at
least 1 week. The weighted mean difference was calculated for net changes in BP by
using ﬁxed-effects or random-effects models. Previously deﬁned subgroup analyses
were performed to explore the inﬂuence of study characteristics.
Results: 21 eligible randomized controlled trials with 1323 subjects were enrolled.
After the tea intake, the pooled mean systolic and diastolic BP were 1.8 mmHg
(95% conﬁdence interval [CI], 2.4- 1.1 mmHg) and 1.4mmHg (95% CI, 2.2-
0.6 mm Hg) lower, respectively, compared with the tea-free controls. Subgroup
analyses showed that the BP-lowering effect was apparent in the subjects who
consumed a tea over a median of 12 weeks (systolic/diastolic BP, -2.6/-2.1 mmHg,
both P <0.001). Stratiﬁed by type of tea, green tea signiﬁcantly reduced systolic and
diastolic BP of -2.1 (95% CI, 2.9- 1.2) and -1.7 (95% CI, 2.9- 0.5) mm Hg,
and black tea signiﬁcantly reduced systolic and diastolic BP of -1.4 (95% CI, 2.4-
0.4) and -1.1 (95% CI, -1.9- 0.2) mm Hg, respectively. The beneﬁts of tea intake
were not inﬂuenced by ethnicity, treatment dose of tea catechins, individual health
status, or caffeine intake.
Conclusions: The meta-analysis showed that long-term (12 weeks) ingestion
of a tea (green and black tea) resulted in a signiﬁcant reduction in systolic and
diastolic BP.C112 JACC Vol 64/16/Suppl C j October 16Diabetes
GW25-e2327
Relationship between plasma musclin levels and insulin resistance in patients
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Objectives: Musclin is a skeletal muscle-derived secretory factor discovered in
2004. A limited number of studies have addressed the relationship between
musclin levels and the alterations of endogenous musclin in type 2 diabetes mel-
litus (T2DM). To ﬁll this blank, this study examined the changes of musclin levels
in plasma and therefore indicated the association between musclin levels and
T2DM.
Methods: In this hospital-based case-control study, 38 newly diagnosed T2DM
subjects who never received anti-diabetic therapy, 41 T2DM subjects under insulin
treatment were enrolled from outpatient department of the Second Afﬁliated Hos-
pital of Harbin Medical University, and the 41 normal subjects with no medical
history were recruited from the health check-up population of our hospital. Fasting
plasma glucose (FPG), serum insulin, hemoglobin A1c (HbA1c) and blood lipid
proﬁle were determined using commercially available diagnostic reagents at the
clinical biochemical laboratories. Plasma musclin levels were measured by
radioimmunoassay.
Results: Plasma musclin levels were signiﬁcantly higher in the newly diagnosed
T2DM group compared with the normal group (83.0716.16 ng/L vs 93.1815.50
ng/L, P <0.01) and were signiﬁcantly decreased in T2DM patients with insulin
therapy (93.1815.50 ng/L vs 83.7419.12 ng/L, P<0.05). Musclin levels in
plasma of newly diagnosed T2DM patients were positively correlated with FPG
(r¼0.467, P<0.01), HbA1c (r¼0.383, P<0.05), serum insulin (r¼0.551, P<0.01),
triglycerides (r¼0.452, P<0.01) and homeostasis model assessment of insulin
resistance (HOMA-IR) (r¼0.388, P<0.05). High-density lipoprotein cholesterol
(HDL-C) levels were negatively correlated with musclin levels (r¼-0.339,
P<0.05).
Conclusions: An upregulation of plasma musclin level increase the risk of T2DM.
There might be a connection between musclin and the pathogenesis of T2DM.
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Objectives: The atherosclerosis risk in communities (ARIC) study have demonstrated
that lower heart rate variability (HRV) is associated with the development of coronary
heart disease (CAD) in individuals with diabetes. However, the relationship between
blood glucose variability and HRV remains unclear. The present study aimed to
explore the impact of glucose variability on HRV in patients with type 2 diabetes
mellitus (T2DM).
Methods: According to glucose variability, assessed by mean amplitude of gly-
cemic excursions (MAGE) obtained from continuous glucose monitoring sys-
tem(CGMS), 68 consecutive type 2 diabetic patients without CAD were divided
into two groups: subjects with non-glucose ﬂuctuation (MAGE<3.9 mmol/l,
n¼32) and subjects with glucose ﬂuctuation (MAGE>¼3.9mmol/l, n¼36). Thirty
healthy controls (NC) were also enrolled. HRV was assessed by dynamic elec-
trocardiogram examination. HRV analysis included time domain parameters such
as SDNN, SDANN, rMSSD and pNN50, and total spectral power (TP) of HRV,
which mainly consists of VLF, LF and HF component along with LF/HF ratio, was
also obtained.
Results: Compared with NC, all the time domain measures were signiﬁcantly lower
in T2DM (SDNN: 92.2.823.1 vs 121.727.4, P<0.05; SDANN: 78.722.9 vs
106.222.5, P<0.05; rMSSD: 27.510.2 vs 35.710.1, P<0.05; and pNN50:
6.07.1 vs 8.87.8, P<0.05). For frequency domain, LF and HF were signiﬁcantly
lower in T2DM (LF:300.2237.8 vs 398.7277.5, P<0.05; HF: 141.8121.5 vs
186.5171.5, P<0.05) whereas VLF and LF/HF ratio were comparable (P>0.05). In
cases with glucose ﬂuctuation, SDNN(79.122.1 vs 100.824.1, P<0.05), SDANN
(61.323.8 vs 88.720.9, P<0.05), rMSSD (23.110.5 vs 29.311.5, P<0.05),
PNN50 (4.96.6 vs 6.56.1, P<0.05), TP (1290.8902.3 vs 1727.01131.5,
P<0.05) and HF (102.1110.7 vs 139.8122.4, P<0.05) were all signiﬁcantly
lower than those in non-glucose ﬂuctuation subjects. No signiﬁcant differences in
VLF (1190.4861.6 vs 1285.6858.0, P>0.05) and LF (274.9223.0 vs–19, 2014 j GW-ICC Abstracts/Epidemiology, Prevention and Control
280.2233.7, P>0.05) were found between the two groups, while LF/HF ratio was
signiﬁcantly higher in glucose ﬂuctuation patients than in non-glucose ﬂuctuation
subjects (2.70.4 vs 2.00.5, P<0.01). Negative correlations of MAGE with
SDNN, SDANN, and HF (r ¼ -0.611, -0.601, -0.542, respectively, P<0.05)
were found in diabetics, while MAGE was positive correlated with LF/HF ratio
(r ¼ 0.594, P<0.05).
Conclusions: Blood glucose variability could lower the HRV of the patients with
T2DM, which relates to impairing the cardiac autonomic nerve function and con-
tributes to the risk of CAD among individuals with diabetes.GW25-e0866
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Objectives: To investigate the effect of experimental acupuncture-meridian treatment
for patients with impaired glucose regulation.
Methods: We selected 59 patients with impaired glucose regulation. There are 31
patients in control group with general advices only but without positive interventions.
There are 28 patients in group of experimental acupuncture-meridian treatment one
month. This group includes three sub-groups: Zusanli (ST36) group, Zusanli (ST36) +
Shousanli (LI10) group, Zusanli (ST36) + Sanyinjiao (SP6) group. We measure and
compare blood pressure, body weight, body mass index (BMI), waist - height ratio
(WSR), OGTT (0 minute, 30 minutes, 60 minutes, 120 minutes, 180 minutes), the
average glucose, area under the curve of blood glucose (AUCg), glycosylated he-
moglobin (HbA1c), area under the curve of insulin (AUCI) and insulin resistance
index (HOMA-IR), IS index (Matsuda index), beta cell function index (OI30/
OG30 IR, MBCI, I phase Stumvoll index) between groups.
Results: The values before treatment of Zusanli (ST36) + Sanyinjiao (SP6) group are
OGTT (60 minutes) 11.020.83mmol/L, OGTT (120 minutes) 9.060.85 mmol/L,
the average glucose 8.100.62 mmol/L, and AUCg 26.281.89 mmol/L.h. The
values after the experimental acupuncture-meridian treatment for one month in
Zusanli (ST36) + Sanyinjiao (SP6) group are OGTT (60 minutes) 9.771.01 mmol/
L,OGTT (120min) 6.981.85 mmol/L, the average glucose 7.320.94 mmol/L, and
AUCg 22.923.32 mmol/L.h, which has declined with signiﬁcant differences than the
values before treatment (P<0.05). It also declines with signiﬁcant differences
compared with other three groups of patients (P<0.05).
Conclusions: In the experimental acupuncture-meridian treatment for patients with
impaired glucose regulation, Zusanli (ST36) + Sanyinjiao (SP6) is signiﬁcantly
effective for management of postprandial hyperglycemia. It is important to the delay
the onset of type 2 diabetes and reduces the occurrence of cardiovascular events, and
prevents the occurrence of serious diabetic microvascular complications.GW25-e1581
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Objectives: The present study aimed to identify the relationship between blood
glucose variability and the 10-year cardiovascular disease (CVD) risk in patients with
type 2 diabetes mellitus (T2DM).
Methods: A set of 68 consecutive T2DM patients without history of CVD were
included to assess blood glucose variability using mean amplitude of glycemic ex-
cursions (MAGE), which was obtained by continuous glucose monitoring system
(CGMS). Then patients were divided into two groups: subjects with non-glucose
ﬂuctuation (MAGE<3.9mmol/l, n¼32) and subjects with glucose ﬂuctuation
(MAGE>¼3.9mmol/l, n¼36). The 10-year cardiovascular disease (CVD) risks were
calculated by the general Framingham Risk Score and compared between two groups.
Correlation analysis of MAGE and the CVD risk was also performed.
Results: The mean T2DM duration was 3.6 years, without signiﬁcant difference
between two groups. The average Framingham Risk Score was 26.42% (Ranged
from 13.77% to 39.65%) in subjects with non-glucose ﬂuctuation, versus 38.64%
(Ranged from 17.02% to 63.92%) in patients with glucose ﬂuctuation (P<0.05).
The proportion of high CVD risk (Framingham Risk Score >20%) was 51.3% in
subjects with non-glucose ﬂuctuation, while it was as high as 72.5% in patients
with glucose ﬂuctuation (P<0.05). Correlation analysis showed that MAGE was
positive correlated with the 10-year CVD risk in T2DM patients (r ¼ 0.543,
P<0.05).
Conclusions: Blood glucose ﬂuctuation contributes to the the development of CVD in
individuals with type 2 diabetes mellitus.JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/EGW25-e3148
New American Diabetes Association diagnostic criteria for screening previously
unknown diabetes in patients undergoing elective coronary angiography
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Objectives: Glycosylated hemoglobin (HbA1c) has become a key component of new
American Diabetes Association (ADA) diagnostic criteria for diabetes, which is not
included in the World Health Organization (WHO) 1999 criteria. Thus, we aimed to
compare WHO 1999 and new ADA diagnostic criteria for diabetes in Chinese non-
acute coronary syndrome (ACS) patients.
Methods: Non-ACS patients who had undergone elective coronary angiography
(CAG) in PUMCH without previously known diabetes were enrolled consecutively
from October 2013 to April 2014. Glucose metabolism abnormalities were evaluated
by fasting plasma glucose (FPG), 2-hour oral glucose tolerance test (2h-OGTT), and
HbA1c level before CAG. WHO recommended FPG7.0mmol/L and/or 2h-OGTT
glucose11.1mmol/L as the diagnostic criteria for diabetes, while ADA recom-
mended HbA1c6.5% as an additional diagnostic criterion.
Results: One hundred and thirty-nine patients (male: 88/139, 63.3%; age: [61.910.1]
years) were included. According to WHO 1999 criteria, 34 patients (24.4%) had
normal glucose regulation, 1 (0.7%) had impaired fasting glucose, 56 (40.3%) had
impaired glucose tolerance and 48 (34.5%) had newly diagnosed type 2 diabetes
mellitus (T2DM). ADA criteria diagnosed 8 more patients with T2DM than WHO
criteria, and those 8 patients had a higher female proportion (75% vs 31.3%,
P¼0.018), lower hemoglobin and hematocrit level [(124.8817.74) g/L vs
(140.1515.17) g/L, P¼0.013, (37.194.30) % vs (40.904.05) %, P¼0.021] as
well as a higher ﬁbrinogen level [(3.470.41) g/L vs (3.020.68) g/L, P¼0.024],
when compared with those diagnosed by both criteria.
Conclusions: Non-ACS patients who were admitted for elective CAG had a high
incidence of abnormal glucose metabolism. Compared with WHO 1999 criteria, new
ADA criteria with HbA1c assessment are able to identify more previously unknown
diabetes patients. Thus, HbA1c level may need to be measured routinely for screening
diabetes in patients undergoing elective CAG, especially for female patients with
lower hemoglobin level and higher ﬁbrinogen level.
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Predictive value of “Visceral Adiposity Index” for Type 2 Diabetes mellitus:
A 15-year prospective cohort study
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Objectives: An emerging term “Visceral Adiposity Index (VAI)” was reported to be
strongly correlated with glycaemic disturbances and diabetes risk, while little infor-
mation is known whether VAI could predict future type 2 diabetes mellitus (DM).
This study aims to assess the predictive value of VAI for DM in general Chinese
population.
Methods: This prospective cohort study was conducted based on a 15-year follow up
in a general Chinese population from an urban community. 711 subjects received
health examination in 1992, and in 2007 the same examination was performed for
them again. 24 were excluded from analysis since DM was diagnosed at baseline.
Waist circumference (WC), body mass index (BMI), VAI and cardiovascular risk
factors were collected at baseline.
Results: 74 individuals developed into DM during a follow up of 15 years. Risks of
future DM increased with increasing levels of VAI. Compared with the lowest
quartile, the highest quartiles of the 3 measures could statistically increase the risk for
the new onset of diabetes (HR¼2.90, 4.48 and 3.31 for BMI, WC and VAI respec-
tively). However, no statistic difference was found between the discriminatory power
of them (AUC¼0.668, 0.701 and 0.649 for BMI, WC and VAI respectively.)
Conclusions: VAI could predict independently in Chinese population, while the
predictive power is not better than that of simple anthropometric measures (BMI and
WC). Our study does not support the clinical application of VAI, and more studies
based on different races are needed to be performed.
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Is Pulse Pressure a Predictor of Diabetes in Chinese Han Nationality
Population?: 15-year prospective study in Chengdu Community
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Objectives: To examine whether pluses pressure (PP) could predict diabetes idcidence
in a Chinese population during a 15-year follow-up.
Methods: The data were collected in 1992 and then again in 2007 from the same
group of 687 individuals. Questionnaire, physical examination and laboratory tests
were performance by a standard protocol. To assess the effects of baseline PP on
the new onset of diabetes, Cox’s proportional hazards regression models were used
to estimate the hazard ratios, and the discriminatory power of anthropometric
measures for diabetes was assessed by the area under the receiver operating curve
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